Please Wait
Applying Filters...
Menu
Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 2GENZYME CORP

02 1ALNYLAM PHARMS INC

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothSanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.

RLD : Yes

TE Code :

FITUSIRAN SODIUM

Brand Name : QFITLIA

Dosage Form : SOLUTION;SUBCUTANEOUS

Dosage Strength : EQ 20MG BASE/0.2ML (EQ 20MG BASE/0.2ML)

Approval Date : 2025-03-28

Application Number : 219019

RX/OTC/DISCN : RX

RLD : Yes

TE Code :

Sanofi Company Banner

02

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothSanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.

RLD : Yes

TE Code :

FITUSIRAN SODIUM

Brand Name : QFITLIA

Dosage Form : SOLUTION;SUBCUTANEOUS

Dosage Strength : EQ 50MG BASE/0.5ML (EQ 50MG BASE/0.5ML)

Approval Date : 2025-03-28

Application Number : 219019

RX/OTC/DISCN : RX

RLD : Yes

TE Code :

Sanofi Company Banner

03

OTS 2025
Not Confirmed
arrow
arrow
OTS 2025
Not Confirmed

GIVOSIRAN SODIUM

Brand Name : GIVLAARI

Dosage Form : SOLUTION;SUBCUTANEOUS

Dosage Strength : EQ 189MG BASE/ML (EQ 189MG BASE/ML)

Approval Date : 2019-11-20

Application Number : 212194

RX/OTC/DISCN : RX

RLD : Yes

TE Code :

blank